LIFECORE BIOMEDICAL, INC. Income Taxes Paid
LIFECORE BIOMEDICAL, INC. (LFCR) reported Income Taxes Paid of $17.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2025-11-06
- LIFECORE BIOMEDICAL, INC. income taxes paid for the quarter ending 2025-09-30 was $17.00K.
- LIFECORE BIOMEDICAL, INC. income taxes paid for the quarter ending 2025-05-25 was -$81.00K, a 4150.00% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. income taxes paid for the quarter ending 2024-08-25 was $0.00.
- LIFECORE BIOMEDICAL, INC. income taxes paid for the quarter ending 2024-05-26 was $2.00K.
- LIFECORE BIOMEDICAL, INC. income taxes paid for fiscal 2025 was $46.00K, a 36.11% decline from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. income taxes paid for fiscal 2024 was $72.00K.
- LIFECORE BIOMEDICAL, INC. income taxes paid for fiscal 2019 was -$1.96M, a 793.64% decline from fiscal 2018.
- LIFECORE BIOMEDICAL, INC. income taxes paid for fiscal 2018 was $283.00K, a 89.86% decline from fiscal 2017.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2025-09-30 | $17.00K 10-Q · filed 2025-11-06 | |||
| 2025-05-25 | -$81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-07 | $46.00K 10-K · filed 2025-08-07 | ||
| 2025-02-23 | $127.00K 10-Q · filed 2025-04-03 | |||
| 2024-08-25 | $0.00 10-Q · filed 2025-11-06 | $2.00K derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-05-26 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-07 | $72.00K 10-K · filed 2025-08-07 | ||
| 2024-02-25 | $70.00K 10-Q · filed 2025-04-03 | |||
| 2019-05-26 | -$1.96M 10-K · filed 2019-08-01 | |||
| 2018-05-27 | $283.00K 10-K · filed 2019-08-01 | |||
| 2017-05-28 | $2.79M 10-K · filed 2019-08-01 | |||
| 2016-05-29 | $2.63M 10-K · filed 2018-08-09 | |||
| 2015-05-31 | $150.00K 10-K/A · filed 2018-03-15 | |||
| 2014-05-25 | $50.00K 10-K · filed 2016-08-01 | |||
| 2013-05-26 | $5.61M 10-K · filed 2015-07-31 | |||
| 2012-05-27 | $246.00K 10-K · filed 2014-08-01 | |||
| 2011-05-29 | $146.00K 10-K · filed 2013-08-07 | |||
| 2010-05-30 | $652.00K 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |